Submitted by Anonymous (not verified) on 21 October 2025 - 14:31
Opinion/decision on a Paediatric investigation plan (PIP): Lojuxta, Lomitapide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Congenital, familial and genetic disorders, PIP number: P/0374/2024
Source: